Genetic Variants May Predict Who Can Benefit from Alcohol Use Disorder Medication
New research suggests that multiple genetic variants can predict individual responses to alcohol addiction medication, paving the way for personalized treatments for AUD.
Recent research highlights the potential of genetic testing in customizing treatments for alcohol use disorder (AUD). A study analyzing data from 285 individuals of European descent treated with the medication topiramate revealed that multiple genetic variants collectively influence treatment outcomes. Unlike prior studies focusing on a single gene, this investigation used polygenic scores—comprehensive measures that aggregate the effects of many genetic variants—to better predict patient responses.
The study focused on four alcohol-related traits: problematic alcohol use (PAU), alcohol consumption levels, time to relapse after treatment, and time to relapse into heavy drinking. Researchers found that higher polygenic scores for these traits correlated with a greater reduction in alcohol-related problems when patients received topiramate. This suggests that genetic risk factors could be used to tailor treatments, helping identify individuals who are most likely to benefit from this medication.
This approach offers a promising direction for personalized medicine in AUD, moving beyond single-gene analyses to consider the complex genetic architecture influencing treatment response. Such insights could improve medication efficacy, increase underused pharmacological interventions, and ultimately enhance recovery outcomes for many patients.
The findings build on existing evidence that genetic factors moderate treatment effectiveness and underscore the importance of large-scale genetic data in developing personalized therapies for addiction. By integrating genetic profiles with clinical assessments, future strategies could optimize treatment plans, reducing trial-and-error prescribing and increasing success rates.
This research was published in "Alcohol: Clinical and Experimental Research" and signifies a meaningful step toward more effective, individualized treatment options for those battling alcohol dependence.
Source: https://medicalxpress.com/news/2025-05-multiple-genetic-variants-benefits-alcohol.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Exploring the Protective Role of ApoE3 Christchurch Against Alzheimer's Disease
New research reveals how the ApoE3 Christchurch variant provides multi-pathway protection against Alzheimer’s, offering hope for future therapies targeting tau buildup and brain health pathways.
Identifying Caregiver Personas to Improve Dementia Medication Management
A groundbreaking study identifies three caregiver personas, enhancing understanding and support strategies for medication management in dementia care, leading to improved patient outcomes.
Exploring the Connection Between Fatigue and Breast Cancer Recurrence
Emerging research indicates a measurable link between fatigue and inflammation in breast cancer survivors, shedding light on new approaches for personalized fatigue management to reduce recurrence risk.
Innovative Milli-Spinner Technique Significantly Boosts Blood Clot Removal Effectiveness
Stanford researchers have developed an advanced thrombectomy device, the milli-spinner, which more than doubles success rates in blood clot removal, promising significant improvements in treating strokes and related conditions. Source: https://medicalxpress.com/news/2025-06-milli-spinner-technique-success-blood.html